$DBX

Analyst recommendations: Dropbox, Etsy, Meta Platforms, Okta

Analysts updated ratings and price targets for several companies. Citi downgraded Dropbox to sell, reducing its target to $29. Arete Research downgraded Etsy to neutral, lowering its target to $81. Goldman Sachs initiated coverage of Madrigal and Revolution with buy ratings and targets of $704 and $267, respectively. Meta was upgraded to buy by President Capital, which raised its target to $897. Paychex was upgraded to neutral by JP Morgan, which raised its target to $115.

Original reporting
Published Sep 24, 2026, 9:09 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 10:13 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$DBX
Bearish
medium confidence
Mentioned
$DBX · $ETSY · $MDGL · $META · $PAYX · $RVMD
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$DBXBearishMed
01

Why it matters

Provides fresh data points for traders to adjust positions based on upgraded or downgraded outlooks.

02

Market read

Rating revisions can trigger short-term price moves; useful for tactical trading.

03

What to watch

Macro environment and earnings trends may dominate price moves more than analyst revisions.

Relevance 5/10Novelty 5/10Timing: today

Background

Daily analyst recommendation roundup highlighting rating changes and target revisions for a set of North American stocks.

Company-level read

Ticker impact

$DBXBearishMedium confidence
Context

Citi downgraded Dropbox to sell and cut price target to $29.

Expected impact

Downward move of 3-5% in near term.

Evidence & confidence

Downgrade and lower target suggest weaker outlook.

$ETSYBearishMedium confidence
Context

Arete Research downgraded Etsy to neutral, lowering target to $81.

Expected impact

Drop of 2-4% shortly after release.

Evidence & confidence

Reduced target reflects weaker growth expectations.

$MDGLBullishMedium confidence
Context

Goldman Sachs resumed coverage of Madrigal Pharmaceuticals with a buy and $704 target.

Expected impact

Potential upside of 5-8% on news.

Evidence & confidence

Buy rating and high target may attract investors.

$METABullishMedium confidence
Context

President Capital Management upgraded Meta to buy, raising target to $897.

Expected impact

Possible 3-6% rally.

Evidence & confidence

Upgrade and higher target signal confidence in growth.

$PAYXNeutralLow confidence
Context

JP Morgan upgraded Paychex to neutral, raising target to $115.

Expected impact

Flat to slight uptick.

Evidence & confidence

Neutral stance offers little new conviction.

$RVMDBullishMedium confidence
Context

Goldman Sachs resumed coverage of Revolution Medicines with a buy and $267 target.

Expected impact

Potential 4-7% gain.

Evidence & confidence

Buy rating and target suggest upside.

$ROLBearishMedium confidence
Context

Piper Sandler downgraded Rollins to neutral, cutting target to $33.

Expected impact

Possible 2-4% decline.

Evidence & confidence

Lower target reflects weaker outlook.

$NCLHBearishMedium confidence
Context

JP Morgan kept Norwegian Cruise Line neutral, reducing target to $13.

Expected impact

Potential 3-5% drop.

Evidence & confidence

Reduced target signals concerns.

Market effects

Analyst rating shifts may influence broader tech and consumer discretionary sentiment.

U.S. equity markets may see modest volatility in affected sectors.

Limited to U.S.-listed companies; minimal global spillover.

Counterpoint

Rating changes could be overreacted; fundamentals remain unchanged.

Key entities

  • Citi

    Downgraded Dropbox.

  • Arete Research

    Downgraded Etsy.

Related articles

$METAMed

Mark Zuckerberg Loses Nearly $9 Billion in One Day as Meta Stock Slides 4% After Goldman Questions AI Spe

Meta Platforms (META) shares fell 4% on Friday, reducing CEO Mark Zuckerberg's net worth by $8.9 billion to $257.5 billion, according to Forbes. The decline followed Goldman Sachs' warning about the high costs of AI infrastructure for companies like Meta. Despite this, analysts like JPMorgan's Doug Anmuth see potential in Meta's AI strategy, including new wearables and VR products, which could generate significant revenue. Meta closed at $751.66, with after-hours trading at $747.82, down 0.51%.

$MSFTMed

Wall Street ends higher on AI stocks buying

Wall Street rose on Friday, led by AI-related stocks like Microsoft (+3.7%), Qualcomm (+4%), and Dell (+5%). Akamai (+3.2%) gained after an $11.6B deal with Anthropic. Meta fell 3.3% despite a 13% weekly gain. S&P 500 (+0.51%), Nasdaq (+0.48%), and Dow (+0.93%) all closed higher.

$PAYXMedAI 8/10

Paychex (PAYX) Beats EPS Estimates, But Slow Growth Weighs on Shares

Paychex (PAYX) reported fiscal Q1 2027 revenue of $1.6B (+6% YoY) and adjusted EPS of $1.34 (+10% YoY), beating estimates. Operating income rose 14% to $619.2M. The company raised guidance for PEO and Insurance Solutions revenue growth to 7-8%. However, total revenue growth outlook remains at 5-6%, and Management Solutions revenue grew just 4%. Shares fell due to slower growth concerns.